In this larger panel it, was clear that, while RALA expression does not vary across BC cell lines, RALB expression is significantly reduced in luminal and TN breast cancer cell lines relative to HER2+ lines (Fig. 5b). Here, ERBB2 is linked to breast carcinoma.